Study flow chart. Abbreviations: BP-DES = biodegradable polymer... | Download Scientific Diagram
1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score–Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents | JACC: Cardiovascular Interventions
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial - The Lancet
3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT | tctmd.com
Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): Rationale and st
BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease | tctmd.com
National Institute for Trial Advocacy | Facebook
Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY Stents | Circulation: Cardiovascular Interventions
EVOLVE & EVOLVE II Clinical Trial Results - Boston Scientific
4. BIORESORT 3 years_Von Birgelen
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial - The Lancet
12-month primary endpoint results of the BIO-RESORT trial, RCT Orsiro vs. Synergy and Resolute Integrity
Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): Rationale and study design of the randomized TWENTE III multicenter trial - ScienceDirect
BIO-RESORT (TWENTE III): A prospective, randomized, three-arm trial comparing two different biodegradable polymer-based drug-eluting stents and a durable. - ppt download
2-year outcome of the 3-arm BIO-RESORT randomised trial in all-comer patients treated with contemporary DES
Orsiro Mission | Orsiro US
BIO-RESORT: 5Y Outcomes | drug eluting stent
BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease
Trial Scorecard: BIO-RESORT (TWENTE III)
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials | Cardiovascular Diabetology | Full Text
FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients | tctmd.com
Trial Scorecard: BIO-RESORT
BIO-RESORT
Stents Drug Eluting | DAIC
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels:
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial. - Abstract - Europe PMC
BIO-RESORT (TWENTE III): A prospective, randomized, three-arm trial comparing two different biodegradable polymer-based drug-eluting stents and a durable. - ppt download
Orsiro Mission | Orsiro US
